Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00102713 · ClinicalTrials.gov registry record · Phase 3
A Study for Treatment of Partial Seizures in Children
A Phase 3 study of Partial Seizures, sponsored by Abbott.
- Completed
- Registry status
- Phase 3
- Development phase
- 50
- Enrollment target
- 10
- Study locations
NCT00102713: Completed Phase 3 study of Partial Seizures, sponsored by Abbott.
NCT00102713 is a Phase 3 study of Partial Seizures that has completed, run by Abbott. The registered enrollment target is 50 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (94% lower). The trial reports 10 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00102713, a Phase 3 study of Partial Seizures, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 50 participants
- Enrollment target
- 10
- Study locations
Study Summary
The purpose of the study is to assess the safety profile of the investigational medication, Depakote Sprinkle Capsules, in the treatment of partial seizures in children ages 3-10.
Conditions Studied
Interventions
- DRUG Divalproex Sodium (Depakote Sprinkle Capsules)
Study Locations (10)
Ohio
- Akron Children's Hospital - Akron
- University Hospitals of Cleveland - Cleveland
Virginia
- Monarch Medical Research - Norfolk
- Virginia Commonwealth University Medical Center - Richmond
Alabama
- Neurology Clinic, P.C. - Northport
Arizona
- St. Joseph's Hospital and Medical Center - Phoenix
Florida
- Pediatric Epilepsy and Neurology Specialists - Tampa
Georgia
- Child Neurology Associates, P.C. - Atlanta
Texas
- Texas Association of Pediatric Neurology, P.A. - San Antonio
Wisconsin
- Richard V. Colan, M.D., S.C. - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2005-02 |
| Phase | Phase 3 |
What the finished NCT00102713 record still lists
NCT00102713 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Partial Seizures appearing as the primary indexed condition, and to 1 intervention - of which Divalproex Sodium (Depakote Sprinkle Capsules) is the first listed.
NCT00102713 lists 10 locations in 8 states (Ohio, Virginia, Alabama).
Frequently Asked Questions
What is clinical trial NCT00102713 about?
NCT00102713 is a clinical study titled "A Study for Treatment of Partial Seizures in Children". The purpose of the study is to assess the safety profile of the investigational medication, Depakote Sprinkle Capsules, in the treatment of partial seizures in children ages 3-10.
What is the current status of trial NCT00102713?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 50 participants. The study started on 2005-02.
What conditions does trial NCT00102713 study?
This clinical trial studies the following conditions: Partial Seizures.
What interventions are being tested in trial NCT00102713?
The interventions under investigation include: Divalproex Sodium (Depakote Sprinkle Capsules) (DRUG).
Who is sponsoring clinical trial NCT00102713?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00102713 being conducted?
This trial has 10 study locations across Alabama, Arizona, Florida, Georgia, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00102713's enrollment target sits among peer trials
50 1844th of 2000 higher than 141 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia